How is healthcare access in Southeast Asia shaping up in 2021?

28 April 2021
southeast-asia_big

A Special Report on the top five trends redefining the way healthcare stakeholders look at long-term healthcare access sustainability in the region from Roshel Jayasundera, director, Global Consulting, Axios International.

Over the last decade, Southeast Asia’s healthcare landscape has evolved considerably. This has been chiefly led by the seismic shifts in disease patterns and population trends, the increase in universal healthcare coverage plans as well as the rise of scientific breakthroughs in healthcare.

However, the landscape has also been defined by the ongoing attempts by stakeholders to overcome persistent gaps within the healthcare access ecosystem – the growth of which has not kept pace with the region’s broader socio-economic development. These realities were put under the microscope during the ongoing COVID-19 pandemic, especially in terms of access.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical